Investor Alert

Intellia Therapeutics Inc.



After Hours

 --Quotes are delayed by 20 min

Jun 24, 2022, 7:58 p.m.





-0.01 -0.02%


Volume 633,882

Quotes are delayed by 20 min


Previous close

$ 50.76

$ 53.41


+2.65 +5.22%

Day low

Day high




52 week low

52 week high




Frank A. G. M. Verwiel

Frank A. G. M. Verwiel is a Dutch businessperson who has been at the head of 6 different companies and holds the position of Chairman for Intellia Therapeutics, Inc. and President at Aptalis Pharma US, Inc. Dr. Verwiel is also on the board of Bavarian Nordic An and Bavarian Nordic GmbH.

Dr. Verwiel previously held the position of Chairman at ObsEva SA, VP-Hypertension & Worldwide Human Health Marketing at Merck & Co., Inc., President, Chief Executive Officer & Director at Aptalis Pharma, Inc., President & Chief Executive Officer at TA SASU, President, Chief Executive Officer & Director at Aptalis Holdings, Inc. and Director & Director-Health Section Governing Board at Biotechnology Innovation Organization.

Dr. Verwiel received an MBA from INSEAD and a doctorate from Erasmus University Rotterdam.


Date Shares Transaction Value
06/14/2022 5,197   Award at $0 per share. 0
06/23/2021 2,094   Award at $0 per share. 0

Officers and Executives

Dr. John M. Leonard
President, Chief Executive Officer & Director
Mr. Glenn Goddard
Treasurer, Chief Financial & Accounting Officer
Dr. Laura Sepp-Lorenzino
Chief Scientific Officer & Executive VP
Dr. Eliana Clark
Chief Technology Officer & Executive VP
Dr. David Lebwohl
Chief Medical Officer & Executive Vice President
Dr. Christine Foster
SVP-Business Development & Alliance Management
Mr. Derek Hicks
Chief Business Officer & Executive Vice President
Mr. Ian Karp
Senior Vice President-Corporate Communications
Ms. Marika St Amand
Chief Human Resources Officer
Mr. James Basta
Secretary, Executive VP & General Counsel
Dr. Frank A. G. M. Verwiel
Mr. John Francis Crowley
Independent Director
Dr. Georgia Keresty
Independent Director
Ms. Muna Bhanji
Independent Director
Dr. Jean-Francois B. Formela
Independent Director
Ms. Caroline D. Dorsa
Independent Director
Dr. Jesse L. Goodman
Independent Director
Dr. Fred Ehrenkranz Cohen
Independent Director
Link to MarketWatch's Slice.